Printed From BioPortfolio.com

Bisphosphonates and denosumab reduce bone density loss in ADT-treated men

06:42 EDT 22 Sep 2017 | Pharmaceutical Journal

Drug interventions can reduce fracture risk in men who receive ADT, but further research is needed.

Original Article: Bisphosphonates and denosumab reduce bone density loss in ADT-treated men

Give dad the gift of knowledge. Order his DNA Ancestry kit this Father's Day for $99 at 23andMe! Ord

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Topics

Bisphosphonates and denosumab reduce bone density loss in ADT-treated men

More From BioPortfolio on "Bisphosphonates and denosumab reduce bone density loss in ADT-treated men"

Relevant Topics

News Quicklinks